プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
tabella 2: provi duet-1 u duet-2
table 2: duet-1 and duet-2 trials
最終更新: 2017-04-26
使用頻度: 1
品質:
bħala analizi trattata tal- provi power u duet.
as treated analysis of the power and duet trials.
最終更新: 2012-04-10
使用頻度: 2
品質:
tabella 4: tagħrif miġbur duet-1 u duet-2
table 4: duet-1 and duet-2 pooled data
最終更新: 2017-04-26
使用頻度: 1
品質:
tagħrif miġbur minn duet- 1 u duet- 2 ġimgħa 24 karatteristiċi linja bażi
duet-1 and duet-2 pooled 24-week data baseline characteristics
最終更新: 2012-04-10
使用頻度: 2
品質:
tabella 3: tagħrif miġbur minn duet-1 u duet-2 ġimgħa 48
table 3: duet-1 and duet-2 pooled 48-week data
最終更新: 2017-04-26
使用頻度: 1
品質:
40 mill- virusis iżolati minn pazjenti li kienu qed jesperjenzaw falliment viroloġiku permezz ta ’ rebound mill- grupp prezista/ rtv 600/ 100 mg b. i. d. tal- provi power u duet, 85% ta ’ dawk suxxettibbli għal darunavir fil- linja bażi żviluppaw suxxettibilità mnaqqsa għal darunavir waqt il- kura.
of the viruses isolated from patients experiencing virologic failure by rebound from the prezista/rtv 600/100 mg b.i.d. group of the power and duet trials, 85% of those susceptible to darunavir at baseline developed decreased susceptibility to darunavir during treatment.
最終更新: 2012-04-10
使用頻度: 5
品質: